Navamedic ASA: Invitation to 2023 2nd quarter presentation Publisert: 07.08.2023 Navamedic ASA: Annual Report for 2022 Publisert: 28.04.2023 Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB Publisert: 22.04.2023 Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million Publisert: 29.03.2023 Navamedic ASA: Q4 2022 financial results Publisert: 16.02.2023 Navamedic ASA: Invitation to 2022 4th quarter presentation Publisert: 13.02.2023 FørsteForrige34567NesteSiste
Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB Publisert: 22.04.2023
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million Publisert: 29.03.2023
